(5-Phenyl-1,3,4-oxadiazol-2-yl)methylamine, 95.0%, 5g

methyl 2-{[(2-ethoxy-4-formylphenoxy)acetyl]amino}benzoate, 100mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-enoic acid, 95.0%, 5g

(1R,2S,4R)-rel-1-Azabicyclo[2.2.1]heptane-2-carboxylic acid hydrochloride), 97%, 250mg

TERT-BUTYL (2,5-DIMETHOXYPHENYL)CARBAMATE, 95.0%, 500mg

Matraces aforados con tapón de vidrio, clase A Forma trapezoidal, 50 ml, 12/21, 2 Unidad(es)

2-Amino-N-[(1,1'-biphenyl)-4-yl]-N-(4-bromophenyl)-9,9-dimethylfluorene>98.0%(HPLC)(N)1g

ETHYL 1-(BROMOMETHYL)CYCLOPROPANECARBOXYLATE, 95.0%, 100mg

Methyl 2,5-dibromothiazole-4-carboxylate, 95.0%, 100g

TERT-BUTYL 6-AMINO-2-OXO-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE, 95.0%, 500mg

(1H-1,2,4-Triazol-1-yl)methanol, 95.0%, 100g

(R)-1-Boc-3-Ethylpiperazine, 95.0%, 5g

(4-Fluoro-phenylamino)-acetic acid, 95.0%, 10g